Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lund

Showing results (551-560 of 826) with videos related to

Pageof 83
Sort By:
Plos Genetics|November 9, 2013
Loss of miR-10a activates lpo and collaborates with activated Wnt signaling in inducing intestinal neoplasia in female miceGustavo Stadthagen, Disa Tehler, Nina Molin Høyland-Kroghsbo, et al.
Cell Reports|March 29, 2024
Initiation of a ZAKα-dependent ribotoxic stress response by the innate immunity endoribonuclease RNase LJiajia Xi, Goda Snieckute, José Francisco Martínez, et al.
Cardiovascular Diabetology|December 2, 2025
Impact of type 2 diabetes on the relationship between chronic kidney disease and cardiovascular outcomes in heart failure across ejection fraction: observational study from the Swedish heart failure and the Swedish National diabetes registriesAurora Merolla, Valeria Valente, Christian Basile, et al.
Journal of the American College of Cardiology|July 3, 2024
Tricuspid Regurgitation in Patients With Heart Failure and Preserved Ejection Fraction: JACC State-of-the-Art ReviewRebecca T Hahn, JoAnn Lindenfeld, Michael Böhm, et al.
European Journal of Heart Failure|August 1, 2024
Characterizing atrial fibrillation in patients with and without heart failure across the ejection fraction spectrum: Incidence, prevalence, and treatment strategiesValeria Valente, Giulia Ferrannini, Lina Benson, et al.
European Journal of Heart Failure|September 27, 2017
A comprehensive population-based characterization of heart failure with mid-range ejection fractionAngela S Koh, Wan Ting Tay, Tiew Hwa Katherine Teng, et al.
Nature Communications|April 29, 2021
The long non-coding RNA MIR31HG regulates the senescence associated secretory phenotypeMarta Montes, Michal Lubas, Frederic S Arendrup, et al.
Journal of Internal Medicine|August 11, 2020
Eligibility for sacubitril/valsartan in heart failure across the ejection fraction spectrum: real-world data from the Swedish Heart Failure RegistryG Savarese, C Hage, L Benson, et al.
European Journal of Heart Failure|December 22, 2023
The role of multimorbidity in patients with heart failure across the left ventricular ejection fraction spectrum: Data from the Swedish Heart Failure RegistryDaniela Tomasoni, Cristiana Vitale, Federica Guidetti, et al.
ESC Heart Failure|June 18, 2020
A registry-based algorithm to predict ejection fraction in patients with heart failureAlicia Uijl, Lars H Lund, Ilonca Vaartjes, et al.
Pageof 83

Showing results (551-560 of 826) with videos related to

Sort By:
Pageof 83
Plos Genetics|November 9, 2013
Loss of miR-10a activates lpo and collaborates with activated Wnt signaling in inducing intestinal neoplasia in female miceGustavo Stadthagen, Disa Tehler, Nina Molin Høyland-Kroghsbo, et al.
Cell Reports|March 29, 2024
Initiation of a ZAKα-dependent ribotoxic stress response by the innate immunity endoribonuclease RNase LJiajia Xi, Goda Snieckute, José Francisco Martínez, et al.
Cardiovascular Diabetology|December 2, 2025
Impact of type 2 diabetes on the relationship between chronic kidney disease and cardiovascular outcomes in heart failure across ejection fraction: observational study from the Swedish heart failure and the Swedish National diabetes registriesAurora Merolla, Valeria Valente, Christian Basile, et al.
Journal of the American College of Cardiology|July 3, 2024
Tricuspid Regurgitation in Patients With Heart Failure and Preserved Ejection Fraction: JACC State-of-the-Art ReviewRebecca T Hahn, JoAnn Lindenfeld, Michael Böhm, et al.
European Journal of Heart Failure|August 1, 2024
Characterizing atrial fibrillation in patients with and without heart failure across the ejection fraction spectrum: Incidence, prevalence, and treatment strategiesValeria Valente, Giulia Ferrannini, Lina Benson, et al.
European Journal of Heart Failure|September 27, 2017
A comprehensive population-based characterization of heart failure with mid-range ejection fractionAngela S Koh, Wan Ting Tay, Tiew Hwa Katherine Teng, et al.
Nature Communications|April 29, 2021
The long non-coding RNA MIR31HG regulates the senescence associated secretory phenotypeMarta Montes, Michal Lubas, Frederic S Arendrup, et al.
Journal of Internal Medicine|August 11, 2020
Eligibility for sacubitril/valsartan in heart failure across the ejection fraction spectrum: real-world data from the Swedish Heart Failure RegistryG Savarese, C Hage, L Benson, et al.
European Journal of Heart Failure|December 22, 2023
The role of multimorbidity in patients with heart failure across the left ventricular ejection fraction spectrum: Data from the Swedish Heart Failure RegistryDaniela Tomasoni, Cristiana Vitale, Federica Guidetti, et al.
ESC Heart Failure|June 18, 2020
A registry-based algorithm to predict ejection fraction in patients with heart failureAlicia Uijl, Lars H Lund, Ilonca Vaartjes, et al.
Pageof 83